DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Blauvelt A, LAcour JP, Fowler Jr JF. et al
Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches.
Br J Dermatol 2018;
179: 623-631 . doi:10.1111/bjd.16890
We do not assume any responsibility for the contents of the web pages of other providers.